May 28, 2026 12:00PM
Apr 29, 2026 07:39AM
Jan 28, 2026 08:04AM
Dec 9, 2025 12:02PM
Dec 1, 2025 12:00PM
Nov 5, 2025 07:46AM
Jul 30, 2025 07:42AM UZEDY® Accelerates: 2025 Revenue Outlook Raised to $190–$200M (from ~$160M); Olanzapine LAI on Track for Submission in 2025
Jun 17, 2025 11:45AM
Jun 10, 2025 12:00PM
May 7, 2025 09:12AM
Mar 31, 2025 02:34PM
Feb 10, 2025 02:00AM
Jan 29, 2025 09:42AM
Dec 10, 2024 11:45AM Medincell Publishes Its Consolidated Half-year Financial Results
Dec 9, 2024 12:00PM
Nov 28, 2024 12:40PM
Nov 6, 2024 07:42AM
Jul 31, 2024 11:45AM
Jun 10, 2024 02:00AM
Jun 3, 2024 12:00PM
May 21, 2024 12:00PM Medincell to Present at the 2024 Jefferies Global Healthcare Conference, June 4 to 6, 2024, New York
Mar 27, 2024 01:00PM
Mar 15, 2024 01:00PM
Feb 15, 2024 12:00PM
Jan 31, 2024 03:59PM
Dec 19, 2023 11:45AM
Dec 11, 2023 12:00PM
Nov 13, 2023 09:38AM MedinCell Applauds Teva and Royalty Pharma Collaboration to Further Accelerate Olanzapine LAI Program (Codename: mdc-TJK or TEV-‘749)
Aug 2, 2023 04:47PM
Jul 31, 2023 11:45AM
Jun 26, 2023 12:06PM
Jun 20, 2023 12:30PM
Dec 6, 2022 12:32PM
Jul 27, 2022 02:00PM
Jul 27, 2022 02:00PM MedinCell’s partner Teva confirms expectation for approval and commercialization in the US in H1 2023 for mdc-IRM/TEV46000
Jun 14, 2022 11:45AM
Jun 7, 2022 12:00PM
May 3, 2022 03:30PM
May 3, 2022 03:20PM
Dec 8, 2021 12:12PM
Dec 9, 2020 12:24PM
Jun 4, 2020 12:30PM MedinCell Announces Fiscal Year Consolidated Results
Jun 4, 2020 11:45AM
Dec 3, 2019 11:58AM
Sep 10, 2019 11:45AM
Jun 4, 2019 11:55AM
Dec 3, 2018 12:20PM

1,198,731 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All